| Watchers | 1,979 |
| 52-Wk Low | $31.52 |
| 52-Wk High | $54.98 |
| Market Cap | $3.4B |
| Volume | 549,642.00 |
| 52-Wk High | $54.98 |
| 52-Wk Low | $31.52 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ultragenyx Pharmaceutical Inc. market cap is $3.4B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ultragenyx Pharmaceutical Inc. 52 week high is $54.98 as of May 11, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ultragenyx Pharmaceutical Inc. 52 week low is $31.52 as of May 11, 2024.
Ultragenyx Pharmaceutical Inc. stock price today is $40.90.
Ultragenyx Pharmaceutical Inc. stock price yesterday was $41.22.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ultragenyx Pharmaceutical Inc.’s P/E ratio is -5.10.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ultragenyx Pharmaceutical Inc. P/B ratio is 24.2296.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Ultragenyx Pharmaceutical Inc.'s EBITDA is -8.09.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ultragenyx Pharmaceutical Inc. 50-day moving average is $46.32.
Ultragenyx Pharmaceutical Inc. has 1,276 employees.